Tata India Pharma & HealthCare Fund Regular Growth+3.95%

1
56.85%
1 Year Return
Equity
Sectoral/Thematic
1.0star
6M
1Y
3Y
All

Fund Details

Tata India Pharma & HealthCare Fund Regular Growth

RiskHigh
Min SIP Amount₹500
Expense Ratio2.63%
NAV14.00 (18 Sep 2020)
Fund Started28 Dec 2015
Fund Size296 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Tata India Pharma & HealthCare Fund Regular Growth
56.9%
18.7%
NA
7.4%
Category Average
60.0%
16.8%
5.8%
-
Rank within category
8
2
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    For how many years?
    1 Year
    3 Years
    Estimated Value
    as per Historical Returns
    0
    with 56.9% annual returns

    Comparison

    Data not available
    Pros
    1. Risk is lower compared to the benchmark
    2. 1Y Returns are higher than the benchmark
    3. 3Y Returns are higher than the benchmark
    Cons
    1. Asset under management(AUM) is less than 500 Crs. Watch expense ratio when AUM is very low
    2. Risk-adjusted returns are lower compared to the category
    3. Higher expense ratio

    Top Holdings

    NameSectorInstrument% Assets
    Dr. Reddy's Laboratories Ltd.HealthcareEquity16.5%
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity15.3%
    Divi's Laboratories Ltd.HealthcareEquity10.8%
    Cipla Ltd.HealthcareEquity8.9%
    Ipca Laboratories Ltd.HealthcareEquity6.1%
    Lupin Ltd.HealthcareEquity5.6%
    Aurobindo Pharma Ltd.HealthcareEquity4.8%
    Narayana Hrudayalaya Ltd.HealthcareEquity4.7%
    Procter & Gamble Health Ltd.HealthcareEquity4.2%
    Natco Pharma Ltd.HealthcareEquity3.2%
    See All

    Fund Managers

    addSailesh Jain
    Education
    Mr. Jain is a Commerce Graduate and an MBA.
    Experience
    Prior to joining TATA Mutual Fund, he has worked with Invesco Mutual Fund, IDFC Securities Ltd. as Head Derivatives, Quant Broking Pvt Ltd. as Vice President and IIFL(India Infoline) as Vice President.
    Funds Managed

    Tata India Pharma & HealthCare Fund Regular Growth Details

    Tata India Pharma & HealthCare Fund Regular Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 28 Dec 2015. Rupesh Patel, Sonam Udasi is the Current Fund Manager of Tata India Pharma & HealthCare Fund Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹296 Cr and the Latest NAV as of 18 Sep 2020 is ₹14.00.

    The Tata India Pharma & HealthCare Fund Regular Growth is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days.

    Investment Objective

    The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

    Tax Implications

    Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

    Scheme Information Document(SID)

    ₹5000
    Min for First Investment
    ₹1000
    Min for Second Investment
    For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days.
    Exit Load

    Compare Funds

    Tata India Pharma & HealthCare Fund Regular Growth
    VS
    search

    About Tata Mutual Fund

    Address
    Mafatlal Centre, 9th Floor, Nariman Point Mumbai 400021
    Phone
    022 6657 8282
    Launch Date
    30 Jun 1995
    Website
    NA
    Tata Mutual Fund
    Asset Management Company
    Custodian
    Standard Chartered Bank
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Similar Funds
    Data not available